Related Experiment Video

Updated: Apr 30, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K

Risks and benefits of statin use in young people with type 1 diabetes

Petter Bjornstad1, R Paul Wadwa

  • 1Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.

Current Diabetes Reports
|May 7, 2014
PubMed

Insights

Cardiovascular disease is a major risk in type 1 diabetes. This review examines the unclear role of statins in managing dyslipidemia and preventing heart issues in young patients with type 1 diabetes.

Area of Science:

  • Endocrinology
  • Cardiology
  • Pediatrics

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in type 1 diabetes (T1D).
  • Macrovascular complications in T1D are not improving despite advances in microvascular care.
  • Dyslipidemia is a key factor in T1D-related CVD, yet often undertreated in adolescents.

Purpose of the Study:

  • To review the current evidence on statin use in children and adolescents with T1D.
  • To clarify the risks and benefits of statins for managing dyslipidemia in this population.
  • To address the controversial role of statins in preventing CVD in young T1D patients.

Main Methods:

  • Literature review of studies on statin efficacy and safety in pediatric populations.
  • Analysis of data concerning dyslipidemia management in type 1 diabetes.
  • Synthesis of evidence regarding cardiovascular risk reduction in adolescents with T1D.

Main Results:

  • Statins are effective and safe for familial hypercholesterolemia in youth.
  • Adults with diabetes benefit from statins, but their use in T1D adolescents is debated.
  • Limited data exists specifically on statin use for T1D-related dyslipidemia in children.

Conclusions:

  • The role of statins in preventing cardiovascular complications in children and adolescents with T1D requires further investigation.
  • Risk-benefit assessment is crucial for considering statin therapy in young T1D patients.
  • Improved management of dyslipidemia is essential for reducing CVD mortality in T1D.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.6K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.3K

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K